Alembic Pharmaceuticals Ltd

Alembic Pharma — DSP Trustee disposal (open market)

• Target Company: Alembic Pharma Limited.
• Disclosing Party: DSP Trustee Private Limited for DSP Mutual Fund, DSP AIF schemes, and DSP Global Funds ICAV.
• Transaction Type: Disposal of voting rights (open market).
• Pre-Transaction Holding: 59,68,340 voting rights, 3.04%.
• Transaction Details: Sold 1,36,574 voting rights (0.07%); Open Market on Sep 24, 2026.
• Post-Transaction Holding: 58,31,766 voting rights, 2.97%.
• Date(s) of Transaction: September 24, 2026.
• Share Capital Context: Before/After—19,65,63,124 equity shares; paid up Rs. 39,31,26,248.
• Total diluted share capital after: 19,65,63,124 shares.

Alembic Pharmaceuticals Limited trading window closed from 1 October 2026 till 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ending 30 September 2026

Meeting Details

• Date and time: 23 September 2026 from 10:00 AM onwards.
• Type/Mode: One-to-one meetings, physical in Mumbai.
• Organiser: Alembic Pharmaceuticals Limited.
• Purpose: Investor interactions with institutional investors/analysts.

Regulatory update

• USFDA inspection at Vadodara Bioequivalence Facility (3–7 Mar 2025) completed; EIR issued.
• Inspection closure communicated to exchanges.

Inspection outcome

• USFDA unannounced onsite bioequivalence inspection at Vadodara facility completed 31 Aug–10 Sep 2026.
• No Form 483 observations reported.

UAE WOS formation

• Wholly Owned Subsidiary named Alembic Pharmaceuticals Global FZCO incorporated in United Arab Emirates on 24 August 2026.
• Intimation of incorporation received by the company on 7 September 2026.
• Holding company is Alembic Pharmaceuticals Limited, with 100% ownership.
• Share capital: AED 100,000 for 100 shares at AED 1,000 each.
• Purpose: explore new opportunities and promote, sell, and distribute pharmaceutical products.
• Nature of consideration: cash; regulatory approvals not applicable.

Meeting Details

• Organizer: Alembic Pharmaceuticals Limited arranging one-to-one investor/analyst meetings.
• Sept 01, 2026 — Dolat Capital; In-Person; Mumbai
• Sept 01, 2026 — Equirus Securities; Virtual; Video Conferencing
• Sept 01, 2026 — 360 ONE Capital; In-Person; Mumbai
• Sept 01, 2026 — ICICI Securities; In-Person; Mumbai
• Sept 01, 2026 — Ashmore (Fund); In-Person; Mumbai
• Sept 01, 2026 — HSBC; In-Person; Mumbai
• Sept 02, 2026 — BOB Capital Markets Ltd; In-Person; Mumbai
• Sept 02, 2026 — Nirmal Bang; In-Person; Mumbai
• Sept 02, 2026 — Yes Securities; In-Person; Mumbai

Appointment details

• Mr. Chirag Shukla appointed as Company Secretary and Compliance Officer (KMP).
• Effective date: 20 August 2026.
• Reason: Appointment to fill governance role.
• Profile: CS and Law graduate with 19+ years' experience.
• Previous roles: Deepak Phenolics Limited; Schaeffler India Limited; Alembic Limited; Bhavnagar Energy.
• Expertise: Companies Act, SEBI Regulations, governance, corporate restructuring.
• Disclosure: Not Applicable for relationships with directors or promoters.
• KMP status conferred to the CS appointment.